Please provide your email address to receive an email when new articles are posted on . Although in-hospital and 30-day mortality is greater among the nearly 1 in 10 patients in the United States who ...

February 7, 2012 (Miami, Florida) — Corneal crosslinking is a procedure that is being used in other countries but has not yet been approved by the US Food and Drug Administration (FDA) in the United ...

SEATTLE, WA — About one in 10 patients in the US have transcatheter aortic-valve replacement (TAVR) for an off-label indication, especially aortic or mitral regurgitation and bicuspid aortic valves, a ...

February 7, 2008 (Chicago, IL) - Doctors and regulators concerned about the spike in off-label patent foramen ovale (PFO) closure procedures now have some numbers to fall back on. A research letter ...

The Lariat device is associated with a significant incidence of death and urgent cardiac surgery during its frequent off-label use to prevent stroke in patients with the irregular heartbeat known as ...

WASHINGTON – Medtronic PLC will pay $2.8 million to the U.S. Justice Department to settle a false-claims case that alleged that the Minnesota devicemaker made illegal payments to doctors to recommend ...